-The Telegraph New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies "escape routes" and promise little relief to consumers, a report released today has warned. The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside...
More »SEARCH RESULT
Total Matching Records found : 124
New drug prices get SC booster dose
-The Telegraph New Delhi: The Supreme Court today ruled that once the government reduces the prices of essential drugs, the new rates would come into immediate effect and companies cannot continue selling at earlier prices. A bench of Justices R.M. Lodha and Kurien Joseph rejected the arguments of multinational giant GlaxoSmithKline Pharma that companies are entitled to sell drugs at old rates for 15 days to dispose off stocks. According to the bench,...
More »Sell drugs at govt rates, not higher prices mentioned on box, says SC -Utkarsh Anand
-The Indian Express The Supreme Court on Monday ruled that drug manufacturers and retailers cannot sell medicines at higher prices mentioned on the label of the boxes if the government notifies a lower rate. They must implement the price fixed under the Drugs (Prices Control) Order (DPCO) within 15 days from the date of notification. The bench of Justices R M Lodha and Kurian Joseph rejected the argument that the revised prices...
More »80% of medicines not covered by price control order -Rema Nagarajan
-The Times of India About 38 million people in India (which is more than Canada's population) fall below the poverty line every year due to healthcare expenses, of which 70% is on purchase of drugs. Yet, the much-awaited Drug Price Control Order (DPCO) 2013, meant to control the price of medicines does not cover over 80% of the medicines in the market. Many drugs crucial for India's disease profile have been...
More »Drug price control covers too little, riddled with loopholes -GS Mudur
-The Telegraph New Delhi: The price caps imposed by the Indian government on 348 drugs earlier this year have created only an illusion of control, keeping many medicines for conditions ranging from asthma to diabetes and heart disease beyond price regulations, experts said today. The price control order issued by the department of pharmaceuticals in May has led to a 22 per cent reduction in the average cost of some 250 medicines,...
More »
